Skip to main content

Felicia Ruffin

Research Program Leader, Tier 1
Medicine, Infectious Diseases
Box 102359 DUMC, Durham, NC 27710
0207 F Hosp South, Durham, NC 27710

Selected Grants


Genomic determinants of antibiotic treatment failure in S. aureus bacteremia

ResearchClinical Research Coordinator · Awarded by National Institutes of Health · 2024 - 2029

Characterization of a Novel E. coli Type III Secretion System Associated with Increased Patient Mortality

ResearchResearch Program Leader · Awarded by National Institutes of Health · 2022 - 2027

HLA Fine Mapping to Elucidate S. aureus Susceptibility - R01 RPPR

ResearchClinical Research Nurse · Awarded by National Institutes of Health · 2021 - 2026

Proof of Principle Study

ResearchClinical Research Coordinator · Awarded by Research of Technologies and Biophotonics LTD · 2024 - 2025

Identification of novel pathogen-specific drug targets in gram-negative bacteria (JCVI CDC U54 - Medium Collaborative)

ResearchResearch Program Leader · Awarded by J. Craig Venter Institute · 2021 - 2025

Innate immune induction of antibiotic tolerance and resistance in Staphylococcus aureus - R56 Bridge Funding (for R01 submission)

ResearchProject Manager · Awarded by University of North Carolina - Chapel Hill · 2022 - 2024

Mentoring Patient Oriented Research in Antibiotic-Resistant Bacteria

ResearchClinical Research Coordinator II · Awarded by National Institutes of Health · 2011 - 2022

Systems Immunobiology of Antibiotic-Persistent MRSA Infections

ResearchClinical Research Coordinator II · Awarded by The Lundquist Institute · 2016 - 2021

Forces at the heart of Staphylococcus biofilms on cardiac implants

ResearchResearch Coordinator · Awarded by Ohio State University · 2014 - 2020

Host Susceptibility to S. aureus

ResearchResearch Associate · Awarded by National Institutes of Health · 2012 - 2020

External Relationships


  • Sanofi
  • Sepsis Alliance

This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.